Sign in Subscribe
Biotechnology industries

Biotie Therapies Corp. Seeks to Raise Up to EUR 9 Million with New Share Issue

Strategic Insights

— 1 min read

Biotie Therapies Corp. aims to bolster its financial standing by offering new shares primarily to existing shareholders, option right holders, and convertible loan holders, with the hope of raising up to approximately EUR 9 million in new capital. The proposed share capital increase involves issuing a maximum of 12 million new shares at a subscription price of EUR 0.75 per share. This move is intended to enhance the company's financial resources and solvency, ensuring the commercialization of its projects and arranging further financing on favorable terms.

Key Takeaways:

  • The proposed share capital increase involves issuing a maximum of 12 million new shares, representing approximately 27% of the company's current share capital.
  • The subscription price for the new shares is set at EUR 0.75 per share.
  • Shareholders, option right holders, and convertible loan holders have a primary right to subscribe for new shares in the event of oversubscription.
  • The subscription period for the offering will be from June 1, 2005, to June 14, 2005.
  • The primary aim of the offering is to improve the company's financial resources and guarantee the commercialization of its projects.
  • Biotie Therapies Corp. aims to secure subscription commitments from its principal shareholders before the commencement of the subscription period.

Statistics:

  • The proposed new capital to be raised through the share issue: up to EUR 9 million.
  • The maximum number of new shares to be issued: 12 million.
  • The subscription price per new share: EUR 0.75.
  • The proposed share capital increase: 27% of the company's current share capital.
  • Subscription period: June 1, 2005, to June 14, 2005.

Sources:

  • Biotie Therapies Corp. - Extraordinary General Meeting Invitation (date not specified)
  • Biotie Therapies Corp. - Proposal to Increase Share Capital (date not specified)
  • Health & Medicine Week (Copyright 2005, NewsRx.com)

Read more